These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 2052583)

  • 1. Genetic basis for p53 overexpression in human breast cancer.
    Davidoff AM; Humphrey PA; Iglehart JD; Marks JR
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):5006-10. PubMed ID: 2052583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance of p53 alterations throughout breast cancer progression.
    Davidoff AM; Kerns BJ; Iglehart JD; Marks JR
    Cancer Res; 1991 May; 51(10):2605-10. PubMed ID: 1850660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 allele losses, mutations and expression in breast cancer and their relationship to clinico-pathological parameters.
    Thompson AM; Anderson TJ; Condie A; Prosser J; Chetty U; Carter DC; Evans HJ; Steel CM
    Int J Cancer; 1992 Feb; 50(4):528-32. PubMed ID: 1537617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in p53 as potential molecular markers for human breast cancer.
    Runnebaum IB; Nagarajan M; Bowman M; Soto D; Sukumar S
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10657-61. PubMed ID: 1961733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.
    Moll UM; Riou G; Levine AJ
    Proc Natl Acad Sci U S A; 1992 Aug; 89(15):7262-6. PubMed ID: 1353891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
    Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P
    Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the p53 gene occur in diverse human tumour types.
    Nigro JM; Baker SJ; Preisinger AC; Jessup JM; Hostetter R; Cleary K; Bigner SH; Davidson N; Baylin S; Devilee P
    Nature; 1989 Dec; 342(6250):705-8. PubMed ID: 2531845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of the p53 gene in human functional adrenal neoplasms.
    Lin SR; Lee YJ; Tsai JH
    J Clin Endocrinol Metab; 1994 Feb; 78(2):483-91. PubMed ID: 8106638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human breast cancer: frequent p53 allele loss and protein overexpression.
    Singh S; Simon M; Meybohm I; Jantke I; Jonat W; Maass H; Goedde HW
    Hum Genet; 1993 Feb; 90(6):635-40. PubMed ID: 8444469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An uncertain role for p53 gene alterations in human prostate cancers.
    Brooks JD; Bova GS; Ewing CM; Piantadosi S; Carter BS; Robinson JC; Epstein JI; Isaacs WB
    Cancer Res; 1996 Aug; 56(16):3814-22. PubMed ID: 8706029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours.
    Prosser J; Thompson AM; Cranston G; Evans HJ
    Oncogene; 1990 Oct; 5(10):1573-9. PubMed ID: 2250913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of p53 and 17p allelic loss in colorectal carcinoma.
    Cunningham J; Lust JA; Schaid DJ; Bren GD; Carpenter HA; Rizza E; Kovach JS; Thibodeau SN
    Cancer Res; 1992 Apr; 52(7):1974-80. PubMed ID: 1551126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data.
    O'Malley FP; Vnencak-Jones CL; Dupont WD; Parl F; Manning S; Page DL
    Lab Invest; 1994 Jul; 71(1):67-72. PubMed ID: 8041120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Missense mutations and a deletion of the p53 gene in human gastric cancer.
    Matozaki T; Sakamoto C; Matsuda K; Suzuki T; Konda Y; Nakano O; Wada K; Uchida T; Nishisaki H; Nagao M
    Biochem Biophys Res Commun; 1992 Jan; 182(1):215-23. PubMed ID: 1370612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 mutations and expression in breast carcinoma in situ.
    Lukas J; Niu N; Press MF
    Am J Pathol; 2000 Jan; 156(1):183-91. PubMed ID: 10623666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between allelic imbalance on 17p, p53 mutation and p53 overexpression in head and neck cancer.
    Götte K; Riedel F; Neubauer J; Schäfer C; Coy JF; Hörmann K
    Int J Oncol; 2001 Aug; 19(2):331-6. PubMed ID: 11445847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis.
    Coles C; Thompson AM; Elder PA; Cohen BB; Mackenzie IM; Cranston G; Chetty U; Mackay J; Macdonald M; Nakamura Y
    Lancet; 1990 Sep; 336(8718):761-3. PubMed ID: 1976143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis.
    Menon AG; Anderson KM; Riccardi VM; Chung RY; Whaley JM; Yandell DW; Farmer GE; Freiman RN; Lee JK; Li FP
    Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5435-9. PubMed ID: 2142531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction to homozygosity involving p53 in esophageal cancers demonstrated by the polymerase chain reaction.
    Meltzer SJ; Yin J; Huang Y; McDaniel TK; Newkirk C; Iseri O; Vogelstein B; Resau JH
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4976-80. PubMed ID: 2052580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the p53 gene in primary human breast cancers.
    Osborne RJ; Merlo GR; Mitsudomi T; Venesio T; Liscia DS; Cappa AP; Chiba I; Takahashi T; Nau MM; Callahan R
    Cancer Res; 1991 Nov; 51(22):6194-8. PubMed ID: 1682043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.